PT - JOURNAL ARTICLE AU - Thierry Prazuck AU - Anne Gravier AU - Daniela Pires-Roteira AU - Aurelie Theillay AU - Sandra Pallay AU - Mathilda Colin AU - Raphael Serreau AU - Laurent Hocqueloux AU - Nino Guy Cassuto TI - Evaluation Of A New “All In One” Sars-Cov-2 Antigen-Detecting Rapid Diagnostic Test And Self-Test: Diagnostic Performance And Usability On Child And Adult Population AID - 10.1101/2021.09.14.21263403 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.14.21263403 4099 - http://medrxiv.org/content/early/2021/09/26/2021.09.14.21263403.short 4100 - http://medrxiv.org/content/early/2021/09/26/2021.09.14.21263403.full AB - The control of the COVID-19 epidemics has been one of top global health priorities for the last eighteen months. To that end, more reliable and easy-to-use diagnostic tests are necessary. Young children are still not eligible to vaccination and it is important to find a way to easily test this key population regularly. With that in mind, we evaluated a new innovative easy two-step self-test named COVID-VIRO ALL IN® developed by AAZ that uses a sampling nasal sponge instead of a classic nasal swab. Mirroring the previous study conducted on the first generation of COVID-VIRO® antigenic self-test, we first performed a multicentre, prospective study on 124 adults and children, in a point-of-care setting. Sensitivity, specificity and overall acceptance of the COVID-VIRO ALL IN® antigen self-test compared to RT-PCR on nasopharyngeal samples were evaluated at 93.02%, 100% and 97,5%, respectively. We then performed a multicentre, prospective, usability study to evaluate the ease of use of COVID-VIRO ALL IN® in real life on 68 laypersons, all adults. Globally, 99% of them considered the instructions material good, 98% executed the procedure well, and all of them interpreted the results correctly. The usability was then specifically investigated on 40 children and teenagers participants, comparing both COVID-VIRO® first generation and the new COVID-VIRO ALL IN®. All of them found COVID-VIRO ALL IN® much easier to use and much more comfortable. For young children, the COVID-VIRO ALL IN® self-test appears to be safer (less risk of trauma compare to nasal swabs and no liquid exposure) easier to use than classic COVID self-tests and giving immediate result which is not the case for RT-PCR done on saliva samples (currently done in routine for kids in French schools). It could be an adapted tool for future mass screening campaigns in schools or at home under adult supervision for kids from the age of 3.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAAZ provided the investigational tests free of charge. No external funding was received Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:COMITE DE PROTECTION DES PERSONNES NORD-OUEST IV 6, rue du Professeur Laguesse CHU LILLE CS 700001 59037 LILLE CEDEX FRANCEAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.